Authors' Response to Young et al: Re Stage III Non-small Cell Lung Cancer Management in England

S. V. Harden; J. B. Adizie; N. Navani; P. Beckett

doi:10.1016/j.clon.2020.05.012

Authors' Response to Young et al: Re Stage III Non-small Cell Lung Cancer Management in England

S. V. Harden
, J. B. Adizie
, N. Navani
, P. Beckett

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	E210
Number of pages	1
Journal	Clinical Oncology
Volume	32
Issue number	10
DOIs	https://doi.org/10.1016/j.clon.2020.05.012
Publication status	Published - 1 Oct 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.clon.2020.05.012

Cite this

@article{9f496ad97dbf4aca9fa8f1d7c3aa0303,

title = "Authors' Response to Young et al: Re Stage III Non-small Cell Lung Cancer Management in England",

author = "Harden, \{S. V.\} and Adizie, \{J. B.\} and N. Navani and P. Beckett",

year = "2020",

month = oct,

day = "1",

doi = "10.1016/j.clon.2020.05.012",

language = "English",

volume = "32",

pages = "E210",

journal = "Clinical Oncology",

issn = "0936-6555",

publisher = "Elsevier",

number = "10",

}

TY - JOUR

T1 - Authors' Response to Young et al

T2 - Re Stage III Non-small Cell Lung Cancer Management in England

AU - Harden, S. V.

AU - Adizie, J. B.

AU - Navani, N.

AU - Beckett, P.

PY - 2020/10/1

Y1 - 2020/10/1

UR - https://www.scopus.com/pages/publications/85087726839

U2 - 10.1016/j.clon.2020.05.012

DO - 10.1016/j.clon.2020.05.012

M3 - Letter

C2 - 32591172

AN - SCOPUS:85087726839

SN - 0936-6555

VL - 32

SP - E210

JO - Clinical Oncology

JF - Clinical Oncology

IS - 10

ER -

Authors' Response to Young et al: Re Stage III Non-small Cell Lung Cancer Management in England

UN SDGs

Access to Document

Other files and links

Cite this